Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC), investigating whether we can […]
Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs On the 24th and 25th July 2023, JDRF Australia was delighted to host a research symposium: T1Decade of Research Progress – Past & Future to commemorate over a decade of achievements of the Type 1 Diabetes Clinical Research Network (T1DCRN). The T1DCRN is […]
JDRF Australia is delighted to announce the recipients of our 2023 PhD top-up scholarships: Rachel Hicks from Western Sydney University and Amanda Purcell from The Kolling Institute. The top-up scholarship is designed to support and encourage PhD students pursuing research in the field of type 1 diabetes (T1D) in line with JDRF’s mission – to […]
JDRF Australia is excited to announce our partnership with Cicada Innovations, leaders in deep tech incubation to accelerate scientific progress and bridge translation gaps. Our partnership will accelerate type 1 diabetes (T1D) research translation and commercialisation through providing resources, mentorship, funding, and networking opportunities. Our goal is to bring scientific discoveries into real-world solutions for […]
A new study has shown drug Verapamil, regularly used to treat blood pressure, can slow type 1 diabetes progression in newly diagnosed children and teens. As researchers work to cure type 1 diabetes (T1D), the ultimate goal is to prevent the destruction of beta cells that produce insulin. A new JDRF-funded clinical trial reveals a […]
MEDIA RELEASE Australia leading type 1 diabetes research with $12M invested to progress landmark study The funding will support the extension of ENDIA, a world-first study seeking to understand the role of environmental triggers from as early as pregnancy for the onset of type 1 diabetes (T1D). 4 April 2023: JDRF Australia and funding partner […]
“The ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D” Dr Kim’s work aims to uncover the link between viruses and type 1 diabetes (T1D). As one of the lead investigators of ENDIA, Dr Kim is looking at whether early infection […]
We sat down with Dr Aveni Haynes to hear from a woman in STEM who inspires in the world of type 1 diabetes (T1D). What drew you to a career in T1D research? “While training to become a doctor, I was fascinated by the complexity and ingenuity of the human body and to date I […]